Skip to main content
SpringerLink
Log in

The Biological Role of lncRNA linc01816 in Esophageal Squamous Cell Carcinoma and Its Correlation with Prognosis

  • HUMAN GENETICS
  • Published:
Russian Journal of Genetics Aims and scope Submit manuscript

Abstract

The present study aimed to explore the expression of linc01816 in esophageal squamous cell carcinoma (ESCC) and its effect on cellular activities of tumor cells, as well as its potential mechanism. RT-qPCR was used to detect the expression levels of linc01816 in human ESCC tissues and cell lines. ESCC cell lines were transfected with linc01816 siRNA and the difference in the proliferation abilities of different groups of cells was detected by CCK-8 method. Transwell method was used to detect the changes in its migration and invasion abilities. Kaplan–Meier curve was conducted to analyze the clinical value of linc01816 in ESCC. The relative expression of linc01816 was overexpressed in ESCC tissues and cells. High linc01816 expression was related to several clinical features and shorter overall survival rate. Compared with negative controls, linc01816 knockdown decreased the viability potential, migration and invasive abilities of ESCC cells, and was partially reversed by miR-326 inhibition. The overexpressed linc01816 was associated with ESCC patients’ overall survival. The proliferation and invasion capacities of ESCC cells can be inhibited by silencing linc01816, which may be related to the regulation of miR-326 expression. Linc01816/miR-326 axis may be a potential prognostic biomarker and therapeutic target for ESCC treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

REFERENCES

  1. Siegel, R.L., Miller, K.D., Fuchs, H.E., et al., Cancer statistics, 2022, CA Cancer J. Clin., 2022, vol. 72, no. 1, pp. 7—33.

    Article  PubMed  Google Scholar 

  2. Li, S., Chen, H., Man, J., et al., Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years, Cancer Med., 2021, vol. 10, no. 5, pp. 1889—1899.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Xia, C., Dong, X., Li, H., et al., Cancer statistics in China and United States, 2022: profiles, trends, and determinants, Chin. Med. J., 2022, vol. 135, no. 5, pp. 584—590.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Watanabe, M., Otake, R., Kozuki, R., et al., Recent progress in multidisciplinary treatment for patients with esophageal cancer, Surg. Today, 2020, vol. 50, no. 1, pp. 12—20.

    Article  PubMed  Google Scholar 

  5. Bhan, A., Soleimani, M., and Mandal, S.S., Long noncoding RNA and cancer: a new paradigm, Cancer Res., 2017, vol. 77, no. 15, pp. 3965—3981.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Li, J., Meng, H., Bai, Y., et al., Regulation of lncRNA and its role in cancer metastasis, Oncol. Res., 2016, vol. 23, no. 5, pp. 205—217.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Smolarz, B., Zadrożna-Nowak, A., and Romanowicz, H., The role of lncRNA in the development of tumors, including breast cancer, Int. J. Mol. Sci., 2021, vol. 22, no. 16, р. 8427. https://doi.org/10.3390/ijms22168427

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Bridges, M.C., Daulagala, A.C., and Kourtidis, A., LNCcation: lncRNA localization and function, J. Cell Biol., 2021, vol. 220, no. 2, р. e202009045.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Herman, A.B., Tsitsipatis, D., and Gorospe, M., Integrated lncRNA function upon genomic and epigenomic regulation, Mol. Cell., 2022, vol. 82, no. 12, pp. 2252—2266.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Jia, J., Li, H., Chu, J., et al., LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis, J. Cancer, 2021, vol. 12, no. 4, pp. 1200—1211.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Liang, Y., Chen, X., Wu, Y., et al., LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein, Cell Death Differ., 2018, vol. 25, no. 11, pp. 1980—1995.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Xue, S.T., Zheng, B., Cao, S.Q., et al., Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis, Mol. Cancer, 2022, vol. 21, no. 1, p. 69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zhao, H., Zhu, X., Luo, Y., et al., LINC01816 promotes the migration, invasion and epithelial‑mesenchymal transition of thyroid carcinoma cells by sponging miR‑34c‑5p and regulating CRABP2 expression levels, Oncol. Rep., 2021, vol. 45, no. 5, р. 82. https://doi.org/10.3892/or.2021.8032

    Article  CAS  Google Scholar 

  14. Kang, D., Jung, I.B., Lee, S.Y., et al., Particulate matter less than 10 μm (PM(10)) activates cancer related genes in lung epithelial cells, Inhal. Toxicol, 2020, vol. 32, nos. 13–14, pp. 487—493.

    Article  CAS  PubMed  Google Scholar 

  15. Fan, X.N., Zhang, S.W., Zhang, S.Y., et al., Prediction of lncRNA-disease associations by integrating diverse heterogeneous information sources with RWR algorithm and positive pointwise mutual information, BMC Bioinf., 2019, vol. 20, no. 1, р. 87. https://doi.org/10.1186/s12859-019-2675-y

    Article  Google Scholar 

  16. Zhang, J., Xiao, F., Qiang, G., et al., Novel lncRNA panel as for prognosis in esophageal squamous cell carcinoma based on ceRNA network mechanism, Comput. Math. Methods Med., 2021, vol. 2021, р. 8020879.

    PubMed  PubMed Central  Google Scholar 

  17. Li, J.H., Liu, S., Zhou, H., et al., starBase v2.0: decoding miRNA-ceRNA, miRNA- ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data, Nucleic Acids Res., 2014, vol. 42, database issue, pp. D92—D97.

  18. Yang, M., Lu, H., Liu, J., et al., LncRNAfunc: a knowledgebase of lncRNA function in human cancer, Nucleic Acids Res., 2022, vol. 50, no. D1, pp. D1295—D1306.

    Article  CAS  PubMed  Google Scholar 

  19. Cai, L., Chen, J.J., Deng, F.M., et al., MiR-326 regulates the proliferation and apoptosis of endometrial cancer by targeting Bcl-2, J. Obstet. Gynaecol. Res., 2021, vol. 47, no. 2, pp. 621—630.

    Article  CAS  PubMed  Google Scholar 

  20. Pan, Y.J., Wan, J., and Wang, C.B., MiR-326: promising biomarker for cancer, Cancer Manage. Res., 2019, vol. 11, pp. 10411—10418.

    Article  CAS  Google Scholar 

  21. Zang, J., Yan, M., Zhang, Y., et al., MiR-326 inhibits trophoblast growth, migration, and invasion by targeting PAX8 via Hippo pathway, Reprod. Biol. Endocrinol., 2022, vol. 20, no. 1, p. 38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Liu, M., Wu, H., Liu, Y., et al., MiR-326 mediates malignant biological behaviors of lung adenocarcinoma by targeting ZEB1, Sci. Prog., 2021, vol. 104, no. 2, р. 368504211009379.

    Article  CAS  PubMed  Google Scholar 

  23. Tang, Y., Yang, P., Zhu, Y., et al., LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro, Thorac. Cancer, 2020, vol. 11, no. 1, pp. 82—94.

    Article  CAS  PubMed  Google Scholar 

  24. Zhao, Y., Yuan, D., Zhu, D., et al., LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p, J. Ovarian Res., 2021, vol. 14, no. 1, p. 109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Xu, M.L., Liu, T.C., Dong, F.X., et al., Exosomal lncRNA LINC01711 facilitates metastasis of esophageal squamous cell carcinoma via the miR-326/FSCN1 axis, Aging (Albany NY), 2021, vol. 13, no. 15, pp. 19776—19788.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Zhang, B., Chu, W., Li, Z., et al., Circ-ATIC serves as a sponge of miR-326 to accelerate esophageal squamous cell carcinoma progression by targeting ID1, Biochem. Genet., 2022, vol. 60, no. 5, pp. 1585—1600.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

No funds, grants, or other support was received.

Author information

Authors and Affiliations

  1. Thoracic Surgery Nursing, Xingtai People’s Hospital, 054001, Xingtai, China

    Y. Jiang

  2. Department of Thoracic Surgery, Xingtai People’s Hospital, 054001, Xingtai, China

    H. Wang

Authors
  1. Y. Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y. Jiang.

Ethics declarations

Conflict of interest. The authors declare that they have no conflicts of interest.

Statement of compliance with standards of research involving humans as subjects. This study was reviewed and approved by the Medical Ethics Committee of Xingtai People’s Hospital, and the patients were informed of the experiment and signed consent form.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, Y., Wang, H. The Biological Role of lncRNA linc01816 in Esophageal Squamous Cell Carcinoma and Its Correlation with Prognosis. Russ J Genet 59 (Suppl 1), 99–105 (2023). https://doi.org/10.1134/S1022795423130082

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1022795423130082

Keywords:

Search

Navigation